You searched for "gases"

3442 results found

Covid-19 ophthalmopathy

Ocular involvement is not uncommon in patients with Covid-19. However, the incidence of Covid-19 ophthalmopathy is unclear. The authors present a prospective case series including 2445 consecutive cases presenting at a neuro-ophthalmology clinic during the last resurgence of SARS-CoV-2 infection....

How common are carotid-cavernous fistulas and what are the neuro-ophthalmic manifestations?

The authors present a retrospective study using the Rochester Epidemiology Project database. The aim was to establish the incidence of carotid-cavernous fistulas (CCF) and outline the associated neuro-ophthalmic patterns. Cases were identified from the database using the following criteria: a...

The approach to trabeculectomy postoperative complications

Performing a trabeculectomy is like giving birth to a baby. It may be traumatic and there is scope for devastating error but once the operation is completed only then does the real work begin. The bleb must be nurtured into...

Conference Report: KCL Ophthalmology Society Annual Conference 2025

King’s College London (KCL) Ophthalmology Society 2024/25 hosted the third Annual KCL Ophthalmology National Conference 2025, entitled ‘Advancements and the Future of Ophthalmology’ in London on 5 April 2025. Held at Guy’s Campus, the event drew a wide audience from...

What's trending Dec/Jan 2026

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #SciFi #Vision Growing up at home, it was my job to read the crossword clues out to my parents. I usually...

Glasgow eye department continues to disrupt ocular simulation training through novel DRV system - the first of many?

Ongoing technological developments are enabling continuous progress to be made across all aspects of medical simulation training. This is particularly true within the field of ophthalmology, where surgical training advancements have enabled the role of simulation to expand dramatically over...

Glasgow eye department continues to disrupt ocular simulation training through novel DRV system - the first of many?

Ongoing technological developments are enabling continuous progress to be made across all aspects of medical simulation training. This is particularly true within the field of ophthalmology, where surgical training advancements have enabled the role of simulation to expand dramatically over...

Orbis Launches #MyEyeStory Campaign with Industry Leaders to Inspire Action and Expand Eye Care for Children

International eyecare charity Orbis is dedicated to ensuring no one loses their sight simply because of where they live. During the recent World Sight Day, Orbis partnered with Babiators, Bausch & Lomb, Corza Medical, and Hoya Vision Care, to expand...

Conj reconstruction with amniotic membrane

This study reports the use of amniotic membrane in patients with restrictive strabismus or conjunctiva problems during or following complex eye muscle surgery. Ambio 5 was used for replacement of conjunctiva in this retrospective study of 32 cases aged one...

How to nearly (but not quite) get into ST1 ophthalmology training – some reflections

Ophthalmology is often considered to be an elite, highly competitive specialty, with little room for failure. Candidates and trainees tend to cultivate a certain urbane and confident style, and the bottleneck at ST1 can feel rather intense. The majority of...

Advances and developments in medical retina

The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...

Rituximab as an immunosuppression treatment for thyroid eye disease

Thyroid eye disease is traditionally treated with high dose glucocorticosteroids and surgical orbital decompression, where responses are often inadequate. This medical treatment is centred around symptom control and reduction of thyroid hormone synthesis, not immunosuppression. Rituximab is an anti-CD20 monoclonal...